43742-1675 NDC - DIZZY (CEREBELLUM (SUIS), BRYONIA (ALBA), PETROLEUM, TABACUM, AMBRA GRISEA, CYCLAMEN EUROPAEUM, NATRUM SALICYLICUM, ARGENTUM NITRICUM, ASARUM CANADENSE, CALCAREA SULPHURICA, CARBONEUM SULPHURATUM, CHININUM SULPHURICUM, COCCULUS INDICUS, CONIUM MACULATUM, DIGITALIS PURPUREA, GELSEMIUM SEMPERVIRENS, PHOSPHORUS, PIPER METHYSTICUM, SILICEA, THERIDION)

Drug Information

Product NDC: 43742-1675

Proprietary Name: Dizzy

Non Proprietary Name: Cerebellum (Suis), Bryonia (Alba), Petroleum, Tabacum, Ambra Grisea, Cyclamen Europaeum, Natrum Salicylicum, Argentum Nitricum, Asarum Canadense, Calcarea Sulphurica, Carboneum Sulphuratum, Chininum Sulphuricum, Cocculus Indicus, Conium Maculatum, Digitalis Purpurea, Gelsemium Sempervirens, Phosphorus, Piper Methysticum, Silicea, Theridion

Active Ingredient(s):
  • 9 [hp_X]/mL AMBERGRIS;
  • 12 [hp_X]/mL ANAMIRTA COCCULUS SEED;
  • 12 [hp_X]/mL ASARUM CANADENSE ROOT;
  • 8 [hp_X]/mL BRYONIA ALBA ROOT;
  • 12 [hp_X]/mL CALCIUM SULFATE ANHYDROUS;
  • 12 [hp_X]/mL CARBON DISULFIDE;
  • 12 [hp_X]/mL CONIUM MACULATUM FLOWERING TOP;
  • 9 [hp_X]/mL CYCLAMEN PURPURASCENS TUBER;
  • 12 [hp_X]/mL DIGITALIS;
  • 12 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT;
  • 8 [hp_X]/mL KEROSENE;
  • 12 [hp_X]/mL MACROPIPER METHYSTICUM ROOT;
  • 12 [hp_X]/mL PHOSPHORUS;
  • 12 [hp_X]/mL QUININE SULFATE;
  • 12 [hp_X]/mL SILICON DIOXIDE;
  • 12 [hp_X]/mL SILVER NITRATE;
  • 10 [hp_X]/mL SODIUM SALICYLATE;
  • 6 [hp_X]/mL SUS SCROFA CEREBRUM;
  • 12 [hp_X]/mL THERIDION CURASSAVICUM;
  • 8 [hp_X]/mL TOBACCO LEAF


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Antimalarial [EPC];
  • Blood Coagulation Factor [EPC];
  • Calcium [CS];
  • Cations;
  • Divalent [CS];
  • Cell-mediated Immunity [PE];
  • Increased Coagulation Factor Activity [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Plant Allergenic Extract [EPC];
  • Plant Proteins [CS]

Labeler Information

Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:9/22/2020

Package Information

No. Package Code Package Description Billing Unit
143742-1675-130 mL in 1 BOTTLE, DROPPER (43742-1675-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-1675The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEDizzyThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECerebellum (Suis), Bryonia (Alba), Petroleum, Tabacum, Ambra Grisea, Cyclamen Europaeum, Natrum Salicylicum, Argentum Nitricum, Asarum Canadense, Calcarea Sulphurica, Carboneum Sulphuratum, Chininum Sulphuricum, Cocculus Indicus, Conium Maculatum, Digitalis Purpurea, Gelsemium Sempervirens, Phosphorus, Piper Methysticum, Silicea, TheridionThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/22/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAMBERGRIS; ANAMIRTA COCCULUS SEED; ASARUM CANADENSE ROOT; BRYONIA ALBA ROOT; CALCIUM SULFATE ANHYDROUS; CARBON DISULFIDE; CONIUM MACULATUM FLOWERING TOP; CYCLAMEN PURPURASCENS TUBER; DIGITALIS; GELSEMIUM SEMPERVIRENS ROOT; KEROSENE; MACROPIPER METHYSTICUM ROOT; PHOSPHORUS; QUININE SULFATE; SILICON DIOXIDE; SILVER NITRATE; SODIUM SALICYLATE; SUS SCROFA CEREBRUM; THERIDION CURASSAVICUM; TOBACCO LEAFAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH9; 12; 12; 8; 12; 12; 12; 9; 12; 12; 8; 12; 12; 12; 12; 12; 10; 6; 12; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Antimalarial [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023